Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

Name: Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Published: 2023
License: Public Domain

GlaxoSmithKline · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

colon coloncancer neoplasms

colonic neoplasms, neoplasms, colon, jemperli, dostarlimab, dostarlimab-gxly, tsr-042, gsk4057190a, folfox, capeox, colon cancer, resectable colon cancer, dmmr/msi

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 801675
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.